Investment & M&A transaction comps
Supplements Investment & M&A Transaction Comps
Explore investment and M&A transactions tagged supplements. Compare companies, buyers, dates and available valuation multiples, with reported, estimated or rumored figures clearly labelled in each comp.
Coverage includes published FundComb transactions carrying this tag. Each comp preserves its own source notes and valuation basis.
- Reviewed transactions
- 16
- With value data
- 9
- With revenue multiples
- 9
- Transaction years
- 2012–2026
Sortable transaction comps
Supplements transaction table
Rows with reported value
9 / 16
Acquisition EV, USD
USD 11B
Investment EV, USD
-
Median EV / revenue
4.0x
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
16 shown of 16 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Thorne Control | 2026-08-04 | Procter & Gamble | USD 3.8B Consideration | 3,800 | 7.6x | - | United States | Estimated 3 sources | ||
| Vitabiotics Control | 2026-07-24 | Bain Capital | USD 1.0B Estimated Enterprise Value | 1,038 | - | - | United Kingdom | Confirmed 3 sources | ||
| Grüns Control (80%) | 2026-04-09 | Unilever | USD 1.2B Enterprise Value | 1,200 | 4.0x | - | United States | Estimated 3 sources | ||
| Sunday Natural Control (55%) | 2024-01-15 | CVC Capital Partners | EUR 800M Enterprise Value | 875 | 8.0x | 16.0x | Germany | Estimated 1 source | ||
| Thorne HealthTech Control | 2023-08-28 | L Catterton | USD 681M Enterprise Value | 681 | 3.7x | 21.2x | - | Estimated 2 sources | ||
| Blackmores Control (100%) | 2023-04-26 | Kirin | USD 1.2B Enterprise Value | 1,241 | 2.9x | 23.1x | Australia | Estimated 3 sources | ||
| The Better Health Company Control | 2022-06-29 | Nestle | Undisclosed Undisclosed | Undisclosed | - | - | New Zealand | Estimated 2 sources | ||
| Smarty Pants Control | 2020-11-25 | Unilever | Undisclosed | Undisclosed | 4.0x | - | - | Confirmed 1 source | ||
| Care/of Control | 2020-08-31 | Bayer | USD 225M | 225 | - | - | United States | Confirmed 1 source | ||
| Vitaco Control | 2016-08-01 | Primavera Capital | Undisclosed | Undisclosed | 1.5x | 14.7x | Australia/New Zealand | Confirmed 1 source | ||
| Swisse Control (83%) | 2015-09-17 | Biostime | AUD 1.7B Enterprise Value | 1,197 | 3.6x | 10.2x | Australia | Confirmed 2 sources | ||
| Schiff Nutrition Control | 2012-11-22 | Reckitt Benckiser | Undisclosed | Undisclosed | 4.2x | 19.1x | - | Confirmed 1 source | ||
| Specnova Control | - | HTBA | Undisclosed | Undisclosed | - | - | United States | Confirmed 2 sources | ||
| Twinlab Brands Control | - | cbdMD | Undisclosed | Undisclosed | - | - | - | Confirmed 2 sources | ||
| Twinlab Control | - | cbdMD | Undisclosed Consideration | Undisclosed | - | - | - | Confirmed 2 sources | ||
| Nestlé Holistic Health Platform Control | - | Yellow Wood Partners | USD 1.0B Consideration | 1,000 | - | - | - | Confirmed 2 sources |
Explore related tags
Continue to the full transaction history for each tag.
Explore buyers & investors
Source coverage varies by transaction. Announced deals, minority investments and capital raises retain their own labels; an investment amount is separate from enterprise value. Read the methodology.